A Pilot Study Evaluating a Novel Biodynamic Imaging (BDI) Method in Predicating Response to Chemotherapy in Locoregional Esophageal Cancer

S
Shadia Jalal, MD

Primary Investigator

Overview

Researchers would like to determine if a new imaging technique called Biodynamic Imagining (BDI) is appropriate for clinical use in the treatment of esophageal cancer. The purpose of this study is to determine if the tumor tissue can be collected, transported and successfully processed using BDI technology.

Description

Researchers would like to determine if a new imaging technique called Biodynamic Imagining (BDI) is appropriate for clinical use in the treatment of esophageal cancer. The purpose of this study is to determine if the tumor tissue can be collected, transported and successfully processed using BDI technology.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    esophageal cancer
  • Age: Between 18 Years - 100 Years
  • Gender: All

Inclusion Criteria
Histologically confirmed adenocarcinoma of the esophagus
Must have a TNM stag I-III disease and no evidence of distant metastasis
Previously untreated for esophageal cancer
Must be medically fit and willing to receive chemoradiation therapy for their disease


Additional Information:
Participants will not be paid for their participation.

Updated on 09 Mar 2024. Study ID: 1412977615 (IUCRO-0486)

Connect with a study center near you

What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center